Share

Reduced Time in Hypoglycemia Demonstrated in Recent Insulin Pump Trial

Positive results were announced this week from the study of a new insulin pump with a predictive low glucose suspend (PLGS) feature. Data showed that the system achieved the primary outcome of reducing time spent in hypoglycemia compared to sensor-augmented pump therapy alone. The company developing the device, Tandem Diabetes Care, is marketing its new...
Share

NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1...
Share

Clock Protein Controls Daily Cycle of Gene Expression by Regulating Chromosome Loops, Study Finds

The up-and-down daily cycles of a long-studied clock protein called Rev-erb coordinates the ebb and flow of gene expression by tightening and loosening loops in chromosomes, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The findings appear online this week in Science First Release. Over the last 15-plus years, a team led by the...
Share

Two Companies to Collaborate on Real-World Diabetes Research

Eli Lilly and Company and Livongo Health today announced a strategic collaboration to study real-world evidence and develop new insights to reduce the burden on people living with diabetes. The research collaboration will combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care. The companies aim to contribute to...
Share

Researchers Detail Snapshot of Proteins That Cause Type 2 Diabetes

Lipid nanodiscs stabilize misfolding protein intermediates red-handed When proteins misfold, accumulate, and clump in insulin-producing cells in the pancreas, they can kill these cells. Now, researchers at the Technical University of Munich (TUM), the University of Michigan, and the Helmholtz-Zentrum Muenchen have obtained a structural snapshot of these proteins when they are most toxic, detailing...
Share

Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed for Up to 42 Years

Researchers in Norway have found very little incidence of end-stage renal disease (ESRD) among those with childhood-onset type 1 diabetes who were followed for up to 42 years, according to a study recently published in Diabetes Care. Researchers led by Torild Skrivarhaug, PhD, of Oslo University Hospital, evaluated patient data for a follow-up period of...

Diabetes Research Articles

Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.